CorMedix Inc. has grown revenue 1077% a year over three years and 339% a year over five. Revenue growth, 3-year annual rate: +1077% (Biotechnology median +17%). Revenue growth, 5-year rate: +339%, growth has picked up over the last three years. Years of annual history on file: 19, FY2007 to FY2025, as filed.

CRMDCorMedix Inc.

Healthcare

$7.31-34% 1Y

$7.31

$6.2552 weeks$12.73

Is it growing?

Excellent

Growing: revenue growing +281% year on year, earnings up +166% year on year, and operating margin widening (+18.5 points).

3 good

Revenue trend+281% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +339% a year.

Earnings trend+166% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing slower than revenue, so the growth is costing something.

Margin direction+18.5 points operating

Trailing-twelve-month operating margin, 46.8% now against 28.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is CRMD growing?

CorMedix Inc. has grown revenue 1077% a year over three years and 339% a year over five.

+1077%

Revenue growth, 3-year annual rate · Biotechnology median +17% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +339%
Revenue growth, 5-year rate · +1077% over three · growth has picked up over the last three years
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed

Details›